---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-009248"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:35:17.256222+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Evofem Biosciences amends supply agreement with UAE partner to add 3-Pack product size

## Summary
- Amendment adds 3-applicator package size (3-Pack) to existing Development and Supply Agreement with Pharma 1 Drug Store L.L.C.
- Pricing for 3-Pack is firm through Dec 31, 2025; specific price redacted as confidential.
- Mixed-size batches (3-Pack and 12-Pack) allowed at Licensor-approved ratios; additional packaging costs paid by Licensee.
- Order lead time remains at least six months; batch size is 96,000 applicators.
- All other terms of the original July 17, 2024 agreement remain unchanged.

## SEC filing metadata
- accession: 0001641172-25-009248
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000164117225009248/0001641172-25-009248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000164117225009248/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-009248
- JSON: https://secwatch.observer/filing/0001641172-25-009248.json
- Plain text: https://secwatch.observer/filing/0001641172-25-009248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.